Sylvia M. Brakenhoff

614 total citations
15 papers, 91 citations indexed

About

Sylvia M. Brakenhoff is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Sylvia M. Brakenhoff has authored 15 papers receiving a total of 91 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 15 papers in Hepatology and 0 papers in Infectious Diseases. Recurrent topics in Sylvia M. Brakenhoff's work include Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (14 papers) and Liver Disease Diagnosis and Treatment (14 papers). Sylvia M. Brakenhoff is often cited by papers focused on Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (14 papers) and Liver Disease Diagnosis and Treatment (14 papers). Sylvia M. Brakenhoff collaborates with scholars based in Netherlands, Canada and Germany. Sylvia M. Brakenhoff's co-authors include Robert J. de Knegt, Milan J. Sonneveld, Robert A. de Man, Harry L.A. Janssen, Annemiek A. van der Eijk, Bettina E. Hansen, André Boonstra, Joost P.H. Drenth, Marc van der Valk and Thomas Berg and has published in prestigious journals such as The Journal of Infectious Diseases, Alimentary Pharmacology & Therapeutics and Viruses.

In The Last Decade

Sylvia M. Brakenhoff

15 papers receiving 89 citations

Peers

Sylvia M. Brakenhoff

EPIDE

HEPAT

IMMUN

Laura Telep United States

R. Balabanska Bulgaria

Sonia Alonso López Spain

Sabine Preisler‐Adams Germany

Adam Jeng Gambia

Tayyab Saeed Akhter Pakistan

Pantong Davwar Nigeria

Elisabeth Trépo France

Lamin Bojang Gambia

Laura Telep United States

Sylvia M. Brakenhoff

69 ×0.8

EPIDE

74 ×1.0

HEPAT

3 ×0.4

3 ×1.0

IMMUN

Citations per year, relative to Sylvia M. Brakenhoff Sylvia M. Brakenhoff (= 1×) peers Laura Telep

Countries citing papers authored by Sylvia M. Brakenhoff

Since Specialization

Citations

This map shows the geographic impact of Sylvia M. Brakenhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia M. Brakenhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia M. Brakenhoff more than expected).

Fields of papers citing papers by Sylvia M. Brakenhoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia M. Brakenhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia M. Brakenhoff. The network helps show where Sylvia M. Brakenhoff may publish in the future.

Co-authorship network of co-authors of Sylvia M. Brakenhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia M. Brakenhoff. A scholar is included among the top collaborators of Sylvia M. Brakenhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia M. Brakenhoff. Sylvia M. Brakenhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Feld, Jordan J., André Boonstra, Sylvia M. Brakenhoff, et al.. (2024). Early HBcrAg and Anti‐HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation—A Pooled Analysis of Two Clinical Trials. Alimentary Pharmacology & Therapeutics. 61(3). 570–578. 2 indexed citations

Brakenhoff, Sylvia M., Heng Chi, Michail Doukas, et al.. (2024). A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report. Case Reports in Gastroenterology. 18(1). 252–259. 1 indexed citations

Boyd, Anders, Sylvia M. Brakenhoff, Rosan A van Zoest, et al.. (2023). Socio‐economic factors associated with loss to follow‐up among individuals with HCV: A Dutch nationwide cross‐sectional study. Liver International. 44(1). 52–60. 2 indexed citations

Brakenhoff, Sylvia M., Mark A. A. Claassen, Pieter Honkoop, et al.. (2023). Sustained response and HBsAg loss after nucleo(s)tide analogue discontinuation in chronic hepatitis B patients: the prospective SNAP study. Clinics and Research in Hepatology and Gastroenterology. 48(2). 102257–102257. 3 indexed citations

Brakenhoff, Sylvia M., et al.. (2022). Assessment of Adherence to Clinical Guidelines in Patients with Chronic Hepatitis B. Viruses. 14(10). 2229–2229. 3 indexed citations

Brakenhoff, Sylvia M., Robert J. de Knegt, Margo J. H. van Campenhout, et al.. (2022). End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients. Journal of Microbiology Immunology and Infection. 56(1). 31–39. 11 indexed citations

Kleef, Laurens A. van, Sylvia M. Brakenhoff, Robert A. de Man, et al.. (2022). Time-trends in disease characteristics and comorbidities in patients with chronic hepatitis B in the period 1980–2020. European Journal of Internal Medicine. 107. 86–92. 9 indexed citations

Brakenhoff, Sylvia M., Pieter Honkoop, Jan G. den Hollander, et al.. (2022). Patients treated with rituximab are poorly screened for hepatitis B infection: Data from a low-incidence country. European Journal of Internal Medicine. 108. 68–73. 1 indexed citations

Brakenhoff, Sylvia M., Robert J. de Knegt, Annemiek A. van der Eijk, et al.. (2022). Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis B. The Journal of Infectious Diseases. 227(1). 113–122. 12 indexed citations

10.

Brakenhoff, Sylvia M., Robert A. de Man, Robert J. de Knegt, Patrick Bindels, & Evelien de Schepper. (2022). Epidemiology and management of hepatitis B and C in primary care in the Netherlands: data from the Rijnmond Primary Care database. Family Practice. 40(1). 83–90. 4 indexed citations

11.

Choi, Hannah, Milan J. Sonneveld, Mina Farag, et al.. (2021). Effects of on‐treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection. Journal of Viral Hepatitis. 28(12). 1729–1737. 8 indexed citations

12.

Brakenhoff, Sylvia M., Wei‐Han Cheng, Hans Blokzijl, et al.. (2021). The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030. Journal of Clinical Medicine. 10(19). 4562–4562. 6 indexed citations

13.

Brakenhoff, Sylvia M., Robert A. de Man, André Boonstra, et al.. (2020). Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss. Alimentary Pharmacology & Therapeutics. 53(2). 314–320. 14 indexed citations

14.

Brakenhoff, Sylvia M., et al.. (2020). Liver stiffness improvement in hepatitis C patients after successful treatment.. PubMed. 78(6). 368–375. 2 indexed citations

15.

Brakenhoff, Sylvia M., et al.. (2020). Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C. BMJ Open Gastroenterology. 7(1). e000396–e000396. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact